Home/Filings/4/0001193125-25-288443
4//SEC Filing

DANTZKER DAVID 4

Accession 0001193125-25-288443

CIK 0000924717other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 6:13 PM ET

Size

18.4 KB

Accession

0001193125-25-288443

Insider Transaction Report

Form 4
Period: 2025-11-19
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-194,6740 total
    Exercise: $28.98Exp: 2030-02-09Common Stock (4,674 underlying)
  • Disposition to Issuer

    Common Stock

    2025-11-1940,1830 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-194,2180 total
    Exercise: $39.58Exp: 2027-02-13Common Stock (4,218 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-192,6050 total
    Exercise: $55.24Exp: 2026-02-13Common Stock (2,605 underlying)
  • Disposition to Issuer

    Employee Stock Options (right to buy)

    2025-11-192,9640 total
    Exercise: $53.86Exp: 2028-02-11Common Stock (2,964 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-193,5550 total
    Exercise: $41.81Exp: 2029-02-10Common Stock (3,555 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-193,8530 total
    Exercise: $31.89Exp: 2031-02-08Common Stock (3,853 underlying)
Footnotes (3)
  • [F1]Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.
  • [F2]As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.
  • [F3]Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.

Documents

1 file

Issuer

SURMODICS INC

CIK 0000924717

Entity typeother

Related Parties

1
  • filerCIK 0001245926

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:13 PM ET
Size
18.4 KB